Insulin Degludec Injection
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jiangsu HengRui Medicine Co., Ltd., The United Bio-Technology (Hengqin) Co., Ltd.
Conditions
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)
Phase 1
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
RecruitingNCT07032688
Start: 2025-08-11End: 2027-04-01Target: 55Updated: 2026-04-17
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
RecruitingNCT07630233
Start: 2026-06-17End: 2026-10-25Target: 53Updated: 2026-09-15